Stereotactic Radiosurgery Plus Whole-Brain Radiation Therapy vs Stereotactic Radiosurgery Alone for Treatment of Brain Metastases: A Randomized Controlled Trial

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Yearbook of Medicine

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Engineering

• Identifiers
  DOI 10.1016/S0084-3873(08)70101-9
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial.

  2006cited by this paper
• Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial.

  2004cited by this paper
• Hypofractionated stereotactic radiotherapy alone without whole-brain irradiation for patients with solitary and oligo brain metastasis using noninvasive fixation of the skull.

  2003cited by this paper
• Risk of symptomatic brain tumor recurrence and neurologic deficit after radiosurgery alone in patients with newly diagnosed brain metastases: results and implications.

  2002cited by this paper
• Application of recursive partitioning analysis and evaluation of the use of whole brain radiation among patients treated with stereotactic radiosurgery for newly diagnosed brain metastases.

  2000cited by this paper
• Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy.

  2000cited by this paper
• Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases.

  1999cited by this paper
• Management of brain metastases.

  1999cited by this paper
• Postoperative Radiotherapy in the Treatment of Single Metastases to the Brain

  1998influential reference
• Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases.

  1998influential reference
• Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials.

  1997cited by this paper
• Stereotactic irradiation without whole-brain irradiation for single brain metastasis.

  1997cited by this paper
• Radiosurgery for the treatment of previously irradiated recurrent primary brain tumors and brain metastases: initial report of radiation therapy oncology group protocol (90-05).

  1996cited by this paper
• Linear accelerator-based stereotaxic radiosurgery for brain metastases:the influence of number of lesions on survival.

  1996influential reference
• A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis

  1996cited by this paper
• A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis.

  1994cited by this paper
• Treatment of single brain metastasis: Radiotherapy alone or combined with neurosurgery

  1993cited by this paper
• A randomized trial of surgery in the treatment of single metastases to the brain.

  1990cited by this paper
• Radiation‐induced dementia in patients cured of brain metastases

  1989cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper
• The stereotaxic method and radiosurgery of the brain.

  1951cited by this paper
• Regression Models and Life-Tables

  year unknowncited by this paper

• Human-like AI-based Auto-Field-in-Field Whole-Brain Radiotherapy Treatment Planning With Conversation Large Language Model Feedback

  2026cites this paper
• Usefulness of local therapy for distant metastases of differentiated thyroid cancer

  2025cites this paper
• BBB-penetrant tyrosine kinase inhibitor plus intracranial radiotherapy vs BBB-penetrant TKI alone in Asians with EGFR-mutated lung adenocarcinoma and brain metastases

  2025cites this paper
• Clinical outcomes following stereotactic radiosurgery for brain metastases from sarcoma primaries: An international multicenter analysis

  2025cites this paper
• MRI distortion correction is associated with improved local control in stereotactic radiotherapy for brain metastases

  2025cites this paper
• Invasion and metastasis in cancer: molecular insights and therapeutic targets

  2025cites this paper
• Tailored radiotherapy for brain metastases improves precision and outcomes

  2025cites this paper
• Roles of SPOCK1 in the Formation Mechanisms and Treatment of Non-Small-Cell Lung Cancer and Brain Metastases from Lung Cancer

  2025cites this paper
• The Effects of Radiation Therapy on the Ocular Apparatus: Implications for Management

  2025cites this paper
• Distant brain failure after stereotactic radiosurgery for brain metastases in patients receiving novel systemic treatments

  2025cites this paper
• Radiotherapy in breast cancer brain metastases: the impact of time interval and disease dynamics when breast cancer seeds to the brain

  2025cites this paper
• Stereotactic radiosurgery for HER2-positive breast cancer brain metastases: prognostic factors and the evolving role of anti-HER2 therapies

  2025cites this paper
• Treatment Outcome of Brain Metastases from Breast Cancer Following Gamma Knife Radiosurgery: A Retrospective Study in Vietnam

  2025influential citation
• Clinical Parameters Associated With Intracranial Progression Burden Following an Initial Stereotactic Radiosurgery Course in a Multi-institutional Brain Metastases Cohort

  2025cites this paper
• Immunotherapy may promote the occurrence of radiation-induced brain injury in NSCLC patients with brain metastases undergoing radiotherapy: a retrospective propensity score-matching and inverse probability of treatment weighting study

  2025cites this paper
• Dosimetric evaluation using EPR/alanine and radiochromic film detectors in end-to-end brain stereotactic radiosurgery sessions

  2025cites this paper
• Comparing simultaneous integrated boost whole‐brain radiotherapy and local irradiation for brain metastases in lung cancer: A retrospective analysis

  2025cites this paper
• 中国驱动基因阳性非小细胞肺癌脑转移临床诊疗指南（2025版）

  2025cites this paper
• Single Pontine Relapse Shortly After Hippocampal Avoidance Whole Brain Radiotherapy: A Case Report

  2025cites this paper
• Clinical features and prognostic factors of ovarian cancer brain metastases from ovarian cancer: a retrospective multicenter study of 129 cases

  2025cites this paper
• Stereotactic Radiosurgery and Stereotactic Fractionated Radiotherapy in the Management of Brain Metastases

  2024influential citation
• Efficacy of Whole-Brain Radiotherapy Plus Simultaneous Integrated Boost (SIB-WBRT) for Lung Cancer Brain Metastases

  2024influential citation
• New Frontiers in the Treatment of Patients with HER2+ Cancer and Brain Metastases: Is Radiotherapy Always Useful?

  2024cites this paper
• Hippocampal avoidance whole-brain radiotherapy with simultaneous integrated boost in lung cancer brain metastases and utility of the Hopkins verbal learning test for testing cognitive impairment in Chinese patients: a prospective phase II study

  2024influential citation
• Leptomeningeal metastatic disease: new frontiers and future directions

  2024cites this paper
• Treatment Options for Brain Metastases

  2024cites this paper
• Upfront Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy in Elderly Patients with Brain Metastases from Non–Small Cell Lung Cancer: A Retrospective Analysis of a 10-Year Bi-institutional Experience

  2024cites this paper
• Prediction of treatment response after stereotactic radiosurgery of brain metastasis using deep learning and radiomics on longitudinal MRI data

  2024cites this paper
• The Japanese breast cancer society clinical practice guidelines for radiation treatment of breast cancer, 2022 edition

  2024cites this paper
• Prognostic Factors and Impact of Therapeutic Intervention in Patients With Brain Metastases at the Initial Presentation

  2024cites this paper
• Tyrosine Kinase Inhibitors With and Without Up-Front Stereotactic Radiosurgery for Brain Metastases From EGFR and ALK Oncogene–Driven Non–Small Cell Lung Cancer (TURBO-NSCLC)

  2024cites this paper
• Breast Cancer Brain Metastasis: A Comprehensive Review

  2024cites this paper
• Stereotactic radiosurgery for brain metastases

  2024cites this paper
• Clinical Practice Guidelines for Brain Metastasis From Solid Tumors

  2024cites this paper
• An Executive Summary of The Philippine Interim Clinical Practice Guidelines for the Diagnosis and Management of Well Differentiated Thyroid Cancer 2021

  2024cites this paper
• Navigating Breast Cancer Oligometastasis and Oligoprogression: Current Landscape and Future Directions

  2024cites this paper
• Preoperative stereotactic radiosurgery for cerebral metastases: safe, effective, and decreases steroid dependency.

  2024cites this paper
• Exploration of radiotherapy strategy for brain metastasis patients with driver gene positivity in lung cancer

  2024influential citation
• A multi-centre stereotactic radiosurgery planning study of multiple brain metastases using isocentric linear accelerators with 5 and 2.5 mm width multi-leaf collimators, CyberKnife and Gamma Knife

  2024cites this paper
• DEGRO guideline for personalized radiotherapy of brain metastases and leptomeningeal carcinomatosis in patients with breast cancer

  2024cites this paper
• Integrating Overall Survival and Tumor Control Probability Models to Predict Local Progression After Brain Metastasis Radiosurgery

  2024cites this paper
• Risk of late radiation necrosis more than 5 years after stereotactic radiosurgery.

  2024cites this paper
• The role of targeted therapy and immune therapy in the management of non-small cell lung cancer brain metastases

  2023cites this paper
• Survival Benefits of Radiotherapy and Surgery in Lung Cancer Brain Metastases with Poor Prognosis Factors

  2023cites this paper
• Stereotactic radiosurgery in brain metastasis: treatment outcomes and patterns of failure

  2023cites this paper
• Outcomes of single brain metastasis treated with gamma knife stereotaxic radiosurgery(GKSR). Our experience on 103 cases

  2023cites this paper
• How many brain metastases can be treated with stereotactic radiosurgery before the radiation dose delivered to normal brain tissue rivals that associated with standard whole brain radiotherapy?

  2023cites this paper
• Stereotactic radiosurgery versus whole-brain radiotherapy after resection of solitary brain metastasis: A systematic review and meta-analysis

  2023cites this paper
• Prospective Evaluation of Response to Treatment, Survival Functions, Recurrence Pattern and Toxicity Profile in Indian Patients with Oligo-Brain Metastasis Treated with Only SRS

  2023cites this paper
• Stereotactic Body Radiation Therapy and Stereotactic Radiosurgery

  2023cites this paper
• Characterization of Central Nervous System Clinico-Genomic Outcomes in ALK-Positive Non-Small Cell Lung Cancer Patients with Brain Metastases Treated with Alectinib.

  2023cites this paper
• Multidisciplinary Management of Brain Metastasis from Breast Cancer.

  2023cites this paper
• Phase II multicenter trial combining nivolumab and radiosurgery for NSCLC and RCC brain metastases

  2023cites this paper
• CyberKnife-based stereotactic radiosurgery or fractionated stereotactic radiotherapy in older patients with brain metastases from non-small cell lung cancer

  2023influential citation
• Biomedical advances and future prospects of high-precision three-dimensional radiotherapy and four-dimensional radiotherapy

  2023cites this paper
• Current Radiotherapy Concepts Regarding Brain and Bone Metastases in Centers Participating in the German-Danish Interreg-Project TreaT

  2023cites this paper
• Gamma Knife Radiosurgery Irradiation of Surgical Cavity of Brain Metastases: Factor Analysis and Gene Mutations

  2023cites this paper
• Upfront and Repeated Stereotactic Radiosurgery in Patients With Brain Metastases From NSCLC.

  2023cites this paper
• Radiosurgery of limited brain metastases from primary solid tumor: results of the randomized phase III trial (NCT02355613) comparing treatments executed with a specialized or a C-arm linac-based platform

  2023cites this paper
• Re-Irradiation by Stereotactic Radiotherapy of Brain Metastases in the Case of Local Recurrence

  2023influential citation
• Comparison between the HyperArc™ technique and the CyberKnife® technique for stereotactic treatment of brain metastases.

  2023cites this paper
• Risk and prognostic factors of brain metastasis in lung cancer patients: a Surveillance, Epidemiology, and End Results population‑based cohort study

  2023cites this paper
• Dosimetric comparison of helical tomotherapy and volumetric modulated arc therapy in hippocampal avoidance whole‐brain radiotherapy

  2023cites this paper
• Gastrointestinal Kanserlerden Gelişen Beyin Metastazı Olan Hastalarda Stereotaktik Radyocerrahiye Yanıtın ve Sağkalım Sonuçlarının Değerlendirilmesi

  2023cites this paper
• AI Evaluation of Imaging Factors in the Evolution of Stage-Treated Metastases Using Gamma Knife

  2023cites this paper
• Surgically targeted radiation therapy (STaRT) for recurrent brain metastases: Initial clinical experience.

  2023cites this paper
• Socio-economic disparities influence likelihood of post-operative radiation to resection cavities of metastatic brain tumors

  2023influential citation
• Is it advisable to perform radiosurgery for EGFR-TKI-controlled brain metastases? A retrospective study of the role of radiosurgery in lung cancer treatment

  2023cites this paper
• Stereotactic Radiosurgery Results in Non-Small-Cell Lung Cancer Patients with Brain Metastases in the Era of Modern Systemic Treatment Agents

  2023cites this paper
• Untoward global effects of current guideline formulation of stereotactic radiotherapy for symptomatic brain metastases by international medical societies

  2023cites this paper
• Successful re-challenge of PD-1 inhibitors in combination with bevacizumab and pemetrexed for multiple primary NSCLC progressing on prior PD-1 inhibitor therapy: one case report

  2023cites this paper
• Stereotactic Radiosurgery for Brain Metastases: Review of Existing Data and Future Directions

  2023cites this paper
• Testing and Treating Cancer with Radation Pharmaceutical Therapy (RPT)

  2023cites this paper
• Differential Distribution of Brain Metastases from Non-Small Cell Lung Cancer Based on Mutation Status

  2023cites this paper
• Perfusion MRI in the evaluation of brain metastases: current practice review and rationale for study of baseline MR perfusion imaging prior to stereotactic radiosurgery (STARBEAM-X)

  2023cites this paper
• Whole-brain Radiotherapy With or Without a Simultaneous Integrated Boost for Treatment of Brain Metastases

  2023cites this paper
• Stereotactic Radiosurgery versus Whole-Brain Radiotherapy in Patients with 4-10 Brain Metastases: A Nonrandomized Controlled Trial.

  2023cites this paper
• PRO: Do We Still Need Whole-Brain Irradiation for Brain Metastases?

  2023cites this paper
• New Radiobiological Principles for the CNS Arising from Space Radiation Research

  2023cites this paper
• Treatment Outcomes After Higher-dose Fractionated Stereotactic Radiotherapy (FSRT) Alone for 1-4 Brain Metastases

  2023cites this paper
• Opportunities and Alternatives of Modern Radiation Oncology and Surgery for the Management of Resectable Brain Metastases

  2023cites this paper
• Management Paradigm of Central Nervous System Metastases in NSCLC: An Australian Perspective

  2023cites this paper
• Optimizing the synergy between stereotactic radiosurgery and immunotherapy for brain metastases

  2023cites this paper
• Letter to the editor regarding the article "Stereotactic radiosurgery versus whole-brain radiotherapy in patients with 4-10 brain metastases: A nonrandomized controlled trial" by Bodensohn et al.

  2023cites this paper
• Modeling Gamma Knife Radiosurgical Toxicity for Multiple Brain Metastases.

  2023cites this paper
• Prognostic analysis of stereotactic radiosurgery for brain metastases: a single-center retrospective study

  2023cites this paper
• Retrospective non-inferiority study of stereotactic radiosurgery for more than ten brain metastases

  2023cites this paper
• Innovative margin design and optimized isocenter to minimize the normal tissue in target volumes for single-isocenter multi-target stereotactic radiosurgery

  2023cites this paper
• Treating brain metastases in metastatic breast cancer: outcomes after stereotactic radiosurgery examined in a retrospective, single-center cohort analysis

  2023cites this paper
• Combined BBB-penetrant tyrosine kinase inhibitor and intracranial radiotherapy versus BBB-penetrant tyrosine kinase inhibitor alone for the treatment of EGFR-mutated non-small cell lung cancer patients with brain metastases

  2023cites this paper
• A modified melanoma-molGPA scoring model: assessment of survival after and efficacy of different radiotherapy modalities in patients with melanoma brain metastases

  2023cites this paper
• Stereotactic radiosurgery in the management of non-small cell lung cancer brain metastases: a prospective study using the NeuroPoint Alliance Stereotactic Radiosurgery Registry.

  2023cites this paper
• Efficacy of Stereotactic Radiosurgery as Single or Combined Therapy for Brain Metastasis: A Systematic Review and Meta-Analysis.

  2023cites this paper
• Adding simultaneous integrated boost to whole brain radiation therapy improved intracranial tumour control and minimize radiation-induced brain injury risk for the treatment of brain metastases

  2023cites this paper
• Comparison of initial and sequential salvage brain-directed treatment in patients with 1–4 vs. 5–10 brain metastases from breast cancer (KROG 16–12)

  2023cites this paper
• Linear accelerator-based stereotactic radiotherapy for brain metastases, including multiple and large lesions, carries a low incidence of acute toxicities: a retrospective analysis

  2023cites this paper
• Proton Beam Therapy in the Oligometastatic/Oligorecurrent Setting: Is There a Role? A Literature Review

  2023cites this paper
• Novel Mechanisms and Future Opportunities for the Management of Radiation Necrosis in Patients Treated for Brain Metastases in the Era of Immunotherapy

  2023cites this paper
• Investigation of Dose Thresholds and Normalization Methods Effect on Gamma Index Analysis for SRT and SBRT Patients with a Monte Carlo Secondary Dose Check Software

  2023cites this paper
• Stereotactic Radiotherapy or Whole-Brain Irradiation Plus Simultaneous Integrated Boost After Resection of Brain Metastases

  2023cites this paper